Myomo, Inc. (MYO) |
|
0.5092 0.009 (1.84%)
|
02-03 14:30 |
|
Open: |
0.5 |
Pre. Close: |
0.5 |
|
High:
|
0.5096 |
Low:
|
0.482 |
|
Volume:
|
316,819 |
Market Cap:
|
4(M) |
|
|
|
Technical analysis |
as of: 2023-02-03 2:18:45 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.67 One year: 0.79 |
| Support: |
Support1: 0.45 Support2: 0.37 |
| Resistance: |
Resistance1: 0.57 Resistance2: 0.67 |
| Pivot: |
0.47  |
| Moving Average: |
MA(5): 0.49 MA(20): 0.47
MA(100): 0.97 MA(250): 2.24 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 76.4 %D(3): 69 |
| RSI: |
RSI(14): 51 |
| 52-week: |
High: 8.07 Low: 0.36 |
| Average Vol(K): |
3-Month: 1,220 (K) 10-Days: 542 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MYO ] has closed below upper band by 15.8%. Bollinger Bands are 72% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.53 - 0.53 |
0.53 - 0.53 |
|
Low:
|
0.47 - 0.48 |
0.48 - 0.48 |
|
Close:
|
0.5 - 0.5 |
0.5 - 0.5 |
|
Company Description |
|
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. |
Headline News |
Wed, 01 Feb 2023
7 Top Short-Squeeze Candidates to Watch in February - InvestorsObserver
Wed, 01 Feb 2023
Myanmar: Two Years After The Tatmadaw’s Coup - Forbes
Tue, 31 Jan 2023
Win Myo Thu – Asia Times - Asia Times
Tue, 31 Jan 2023
Treasury Sanctions Officials and Military-Affiliated Cronies in Burma ... - Treasury
Mon, 30 Jan 2023
Myomo (MYO) Appoints Yitzchak Jacobovitz to its Board - StreetInsider.com
Thu, 26 Jan 2023
Large New Zealand Study Confirms Safety Profile of Pfizer ... - Contagionlive.com
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
7 (M) |
| Shares Float |
6 (M) |
|
% Held by Insiders
|
3.5 (%) |
|
% Held by Institutions
|
37.2 (%) |
|
Shares Short
|
73 (K) |
|
Shares Short P.Month
|
55 (K) |
Stock Financials |
|
EPS
|
-1.76 |
|
EPS Est Next Qtl
|
-0.34 |
|
EPS Est This Year
|
-5.54 |
|
EPS Est Next Year
|
-0.89 |
|
Book Value (p.s.)
|
2.25 |
|
Profit Margin (%)
|
-68.6 |
|
Operating Margin (%)
|
-68 |
|
Return on Assets (ttm)
|
-35.3 |
|
Return on Equity (ttm)
|
-71.5 |
|
Qtrly Rev. Growth
|
127.5 |
|
Gross Profit (p.s.)
|
0.72 |
|
Sales Per Share
|
1.98 |
|
EBITDA (p.s.)
|
-1.34 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-9 (M) |
|
Levered Free Cash Flow
|
-6 (M) |
Stock Valuations |
|
PE Ratio
|
-0.29 |
|
PEG Ratio
|
8.9 |
|
Price to Book value
|
0.22 |
|
Price to Sales
|
0.25 |
|
Price to Cash Flow
|
-0.4 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
